Received Aug 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | 1 | 9X7CD | — |
the administration of a shot of Menveo to a 63-year-old male patient and it was not appropriate for his age; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate age at vaccine administration in a 63-year-old male patient who received Men ACWY-CRM NVS (Menveo) (batch number 9X7CD, expiry date 31-JAN-2026) for prophylaxis. On 18-JUL-2025, the patient received the 1st dose of Menveo. On 18-JUL-2025, an unknown time after receiving Menveo, the patient experienced inappropriate age at vaccine administration (Verbatim: the administration of a shot of Menveo to a 63-year-old male patient and it was not appropriate for his age). The outcome of the inappropriate age at vaccine administration was not applicable. Additional Information: GSK Receipt Date: 23-JUL-2025 On 23 July 2025, a pharmacist called to report the administration of a shot of Menveo to a 63-year-old male patient and it is not appropriate for his age. She wanted to know how to proceed because patient was seeking to have another vaccine in preparation for a travel to . Vaccine was administered on 18 July 2025, one dose.